Home Cart 0 Sign in  
X

[ CAS No. 126325-53-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 126325-53-9
Chemical Structure| 126325-53-9
Chemical Structure| 126325-53-9
Structure of 126325-53-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 126325-53-9 ]

Related Doc. of [ 126325-53-9 ]

Alternatived Products of [ 126325-53-9 ]

Product Details of [ 126325-53-9 ]

CAS No. :126325-53-9 MDL No. :MFCD03095078
Formula : C6H7BrN2 Boiling Point : -
Linear Structure Formula :- InChI Key :KLVZEEUNGGOROA-UHFFFAOYSA-N
M.W : 187.04 Pubchem ID :14418051
Synonyms :

Calculated chemistry of [ 126325-53-9 ]

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.31
TPSA : 38.91 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.3 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.63
Log Po/w (XLOGP3) : 1.6
Log Po/w (WLOGP) : 1.74
Log Po/w (MLOGP) : 0.92
Log Po/w (SILICOS-IT) : 1.78
Consensus Log Po/w : 1.54

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.5
Solubility : 0.59 mg/ml ; 0.00316 mol/l
Class : Soluble
Log S (Ali) : -2.03
Solubility : 1.75 mg/ml ; 0.00936 mol/l
Class : Soluble
Log S (SILICOS-IT) : -2.91
Solubility : 0.232 mg/ml ; 0.00124 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.75

Safety of [ 126325-53-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 126325-53-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 126325-53-9 ]
  • Downstream synthetic route of [ 126325-53-9 ]

[ 126325-53-9 ] Synthesis Path-Upstream   1~2

  • 1
  • [ 80287-53-2 ]
  • [ 126325-53-9 ]
Reference: [1] Journal fuer Praktische Chemie (Leipzig), 1989, vol. 331, # 3, p. 369 - 374
[2] Journal fuer Praktische Chemie (Leipzig), 1989, vol. 331, # 3, p. 369 - 374
  • 2
  • [ 126325-53-9 ]
  • [ 374633-36-0 ]
YieldReaction ConditionsOperation in experiment
38%
Stage #1: With hydrogenchloride; sodium nitrite In water at -5 - 0℃;
Stage #2: With hexafluorophosphoric acid In waterCooling
Stage #3: at 100℃; for 0.166667 h;
General procedure: 3-Amino-2-bromo-6-methylpyridine(7a) or4-amino-2-bromo-6-methylpyridine(7b) (25.20 g, 134.73 mmol) wasadded to a mixture of water (78.1 mL) and conc. HCl (12.8 mL, 350.30 mmol), andthen the mixture was cooled to 0 oC. To it, sodium nitrite (18.6 g,269.46 mmol) was added portionwise with stirring over a period of 20 min whilekeeping the reaction temperature between –5 oCand 0 oC. After 10 min, 65percent hexafluorophosphoric acidsolution (43.26 g, 296.41 mmol) was added dropwise with cooling, atwhich point a lot of precipitates were formed. The precipitates were collectedby filteration using a glass filter funnel, washed with cold water (2 × 50 mL) and diethyl ether (100 mL), and then dried in the air for 48 h.The solid was slowly heated to 100 oC (very exothermic), and a darkred oily material was formed after 10 min. The oil was basified with dilutedNaOH solution to pH~10 and extracted with CH2Cl2 (2 × 150 mL). The combined organic layer was dried over anhydrous Na2SO4,filtered, and evaporated to dryness under reduced pressure. The residue waspurified by MPLC on neutral alumina using hexane/EtOAc (10:1) as eluent to affordthe titled compounds.
Reference: [1] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 22, p. 5228 - 5231
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 126325-53-9 ]

Bromides

Chemical Structure| 39856-58-1

[ 39856-58-1 ]

2-Bromopyridin-3-amine

Similarity: 0.91

Chemical Structure| 83004-10-8

[ 83004-10-8 ]

2-Bromo-6-(bromomethyl)pyridine

Similarity: 0.89

Chemical Structure| 5315-25-3

[ 5315-25-3 ]

2-Bromo-6-methylpyridine

Similarity: 0.87

Chemical Structure| 104829-98-3

[ 104829-98-3 ]

2-Bromo-4,6-dimethylpyridin-3-amine

Similarity: 0.87

Chemical Structure| 126325-50-6

[ 126325-50-6 ]

3-Amino-2-bromo-4-picoline

Similarity: 0.80

Amines

Chemical Structure| 39856-58-1

[ 39856-58-1 ]

2-Bromopyridin-3-amine

Similarity: 0.91

Chemical Structure| 104829-98-3

[ 104829-98-3 ]

2-Bromo-4,6-dimethylpyridin-3-amine

Similarity: 0.87

Chemical Structure| 90902-84-4

[ 90902-84-4 ]

2,5-Dibromopyridin-3-amine

Similarity: 0.80

Chemical Structure| 126325-50-6

[ 126325-50-6 ]

3-Amino-2-bromo-4-picoline

Similarity: 0.80

Chemical Structure| 34552-14-2

[ 34552-14-2 ]

3-Amino-2-bromo-5-methylpyridine

Similarity: 0.79

Related Parent Nucleus of
[ 126325-53-9 ]

Pyridines

Chemical Structure| 39856-58-1

[ 39856-58-1 ]

2-Bromopyridin-3-amine

Similarity: 0.91

Chemical Structure| 83004-10-8

[ 83004-10-8 ]

2-Bromo-6-(bromomethyl)pyridine

Similarity: 0.89

Chemical Structure| 5315-25-3

[ 5315-25-3 ]

2-Bromo-6-methylpyridine

Similarity: 0.87

Chemical Structure| 104829-98-3

[ 104829-98-3 ]

2-Bromo-4,6-dimethylpyridin-3-amine

Similarity: 0.87

Chemical Structure| 126325-50-6

[ 126325-50-6 ]

3-Amino-2-bromo-4-picoline

Similarity: 0.80